ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,422Medicare Part D Prescriptions Filled, Including Refills

Rank: 267 out of 1171

$413K Total Retail Price of All Prescriptions

Rank: 301 out of 1171

321 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,221 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LISINOPRIL 241 205 1 3
SIMVASTATIN 222 199 2 1
OMEPRAZOLE 200 165 3 5
AMLODIPINE BESYLATE 198 182 4 2
WARFARIN SODIUM 188 142 5 12
LEVOTHYROXINE SODIUM 150 127 6 4
FUROSEMIDE 146 128 7 6
NAMENDA 140 140 8 42
LEVOFLOXACIN 127 118 9 105
RISPERIDONE 124 109 10 77
MIRTAZAPINE 123 119 11 50
METOPROLOL TARTRATE 122 104 12 11
DONEPEZIL HCL 117 116 13 24
ATORVASTATIN CALCIUM 112 68 14 10
TRAMADOL HCL 107 86 15 18
HYDROCODONE-ACETAMINOPHEN 106 81 S3 16 8
SERTRALINE HCL 100 98 17 23
CITALOPRAM HBR 97 81 18 22
QUETIAPINE FUMARATE 94 93 19 54
GABAPENTIN 92 81 20 16
METFORMIN HCL 88 73 21 7
CARVEDILOL 87 71 22 20
ATENOLOL 86 74 23 15
PANTOPRAZOLE SODIUM 83 59 24 29
FAMOTIDINE 81 67 25 75
EXELON 81 81 25 164
CLOPIDOGREL 79 69 27 35
NOVOLIN R 74 53 28 155
SEROQUEL 71 71 29 120
HYDRALAZINE HCL 66 66 30 60
PRAVASTATIN SODIUM 65 58 31 13
DIOVAN 65 61 31 32
ADVAIR DISKUS 63 49 33 51
LOSARTAN POTASSIUM 62 53 34 14
ESCITALOPRAM OXALATE 60 58 35 69
LANTUS SOLOSTAR 57 48 36 90
DIGOXIN 55 52 37 68
ALBUTEROL SULFATE 52 40 38 102
ZOLPIDEM TARTRATE 51 43 39 21
TRAZODONE HCL 51 42 39 37
CYMBALTA 50 31 41 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.